Key points are not available for this paper at this time.
Design
Editorial
The authors acknowledge the potential role of miRNAs in ARVC pathogenesis and as biomarkers for sudden cardiac death, though noting they are not yet validated for clinical practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2018 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: